Yunnan Weihe Pharmaceutical Co., Ltd. was established on June 65438+February 65438+February 09, 2008, and its headquarters is located in Yuxi City, Yunnan Province. Yunnan Weihe Pharmaceutical Co., Ltd. is engaged in the research and development, production and sales of natural herbs with Panax notoginseng as the main raw material, as well as the cultivation of Chinese herbal medicines such as Panax notoginseng.
The products of Yunnan Weihe Pharmaceutical Co., Ltd. include Xuesaitong series, Sanqi series and other series. Yunnan Weihe Pharmaceutical Co., Ltd. also deals in other medicines such as traumatic injury, expelling wind and removing dampness, dispelling cold and diminishing inflammation, enriching blood and nourishing blood.
As of February 26th, 20 19, Yunnan Peacekeeping Holding Co., Ltd., Shanghai Jingxi Investment Development Center, yingtan Guotai Junan Venture Capital Longxin Investment Center, Dirui Asset Management (Hangzhou) Co., Ltd. and Qi Jiangang held 28. 19%, 7.64%, 4.82% and 4 respectively.
Yunnan Weihe Pharmaceutical Co., Ltd. won the titles of "China Pharmaceutical Industry Law-abiding and Honest Enterprise" and "20 17 China Top 100 National Medicine Brand Enterprise".